CAR-T Therapy In Haematological Malignancy Report

By www.marketgrowthrate.com

Report Details

Report Name

Global CAR-T Therapy In Haematological Malignancy Market Size, Status And Forecast 2024-2031 Story

Pages

105

Price

$ 3900

Features

CAR-T Therapy In Haematological Malignancy Report report is categorised based on following features:

1. Global Market Players

2. Geopolitical regions

3. Consumer Insights

4. Technological advancement

5. Historic and Future Analysis of the Market

Companies Covered

              Celgene (Juno Therapeutics)
Novartis
Gilead (Kite Pharma)
Pfizer
CARsgen Therapeutics
Autolus Therapeutics
Aurora BioPharma
Sorrento Therapeutics
Mustang Bio
Bluebird Bio
Collectis
Allogene Therapeutics
Celyad